Skip to main content
  • Donate Blood (Opens in a new tab/window)
  • About NBA
  • News and updates
  • Resources
  • BloodPortal login (Opens in a new tab/window)
Logo image Logo image
  • Blood Products
    • Blood Products
    • National Product Price List
    • Fresh Blood Products
    • Albumin Products
    • Clotting Factor and Other Products
    • Immunoglobulin Products
      • Immunoglobulin Usage and Data
      • Intravenous Immunoglobulin (IVIg)
      • Subcutaneous Immunoglobulin (SCIg)
      • Normal Human Immunoglobulin (NHIg)
      • Hyperimmune Immunoglobulin Products
    • Access and Ordering
      • BloodSTAR for Ig Products
      • BloodSTAR Registration Form
      • BloodNet for Blood Products from Lifeblood
      • BloodNet System Interface
      • Frequently Asked Questions
    • Blood Product Management
      • Inventory Management
      • Blood Product Wastage
      • Blood and Inventory Management Resources
      • Case Studies
      • Single Unit Transfusion Guide
  • Supply System
    • Supply System
    • Managing Blood Supply
      • Risk Management
      • National Stewardship Program
      • Blood Product Labelling
    • Governance for Immunoglobulin Products
      • National Immunoglobulin Governance Committees
      • Criteria for Immunoglobulin Products
    • Suppliers and Commercial Supply Contracts
      • Fresh Blood Product Supply and Lifeblood
      • Plasma and Recombinant Product Supply
      • Imported Product Supply
      • Red Cell Diagnostic Product Supply
    • Australian Health Provider Access to Blood and Blood Products
    • Overseas Supply of Blood Products
  • Clinical Guidance
    • Clinical Guidance
      • Rh D Ig Guideline (Opens in a new tab/window)
      • PBM Guidelines (Opens in a new tab/window)
    • National Standards
    • Immunoglobulin
    • Patient Blood Management
      • Patient Blood Management (PBM) Resources
    • Transfusion-related Adverse Events
    • Bleeding Disorders
      • Australian Bleeding Disorders Registry (ABDR)
    • eLearning Courses
    • Public Consultations
    • Patient Blood Management Guidelines (Opens in a new tab/window)
  • Data and Research
    • Data and Research
    • Data and Reporting
    • Research Funding Program
      • Successful Grant Rounds
  • Patient Information
    • Patient information
    • Bleeding disorders
    • Blood disorders
    • Travelling with blood products
    • MyABDR app and the ABDR

Search

  • Donate Blood (Opens in a new tab/window)
  • About NBA
  • News and updates
  • Resources
  • BloodPortal login (Opens in a new tab/window)
  • Blood Products
    • Blood Products
    • National Product Price List
    • Fresh Blood Products
    • Albumin Products
    • Clotting Factor and Other Products
    • Immunoglobulin Products
      • Immunoglobulin Usage and Data
      • Intravenous Immunoglobulin (IVIg)
      • Subcutaneous Immunoglobulin (SCIg)
      • Normal Human Immunoglobulin (NHIg)
      • Hyperimmune Immunoglobulin Products
    • Access and Ordering
      • BloodSTAR for Ig Products
      • BloodSTAR Registration Form
      • BloodNet for Blood Products from Lifeblood
      • BloodNet System Interface
      • Frequently Asked Questions
    • Blood Product Management
      • Inventory Management
      • Blood Product Wastage
      • Blood and Inventory Management Resources
      • Case Studies
      • Single Unit Transfusion Guide
  • Supply System
    • Supply System
    • Managing Blood Supply
      • Risk Management
      • National Stewardship Program
      • Blood Product Labelling
    • Governance for Immunoglobulin Products
      • National Immunoglobulin Governance Committees
      • Criteria for Immunoglobulin Products
    • Suppliers and Commercial Supply Contracts
      • Fresh Blood Product Supply and Lifeblood
      • Plasma and Recombinant Product Supply
      • Imported Product Supply
      • Red Cell Diagnostic Product Supply
    • Australian Health Provider Access to Blood and Blood Products
    • Overseas Supply of Blood Products
  • Clinical Guidance
    • Clinical Guidance
      • Rh D Ig Guideline
      • PBM Guidelines
    • National Standards
    • Immunoglobulin
    • Patient Blood Management
      • Patient Blood Management (PBM) Resources
    • Transfusion-related Adverse Events
    • Bleeding Disorders
      • Australian Bleeding Disorders Registry (ABDR)
    • eLearning Courses
    • Public Consultations
    • Patient Blood Management Guidelines
  • Data and Research
    • Data and Research
    • Data and Reporting
    • Research Funding Program
      • Successful Grant Rounds
  • Patient Information
    • Patient information
    • Bleeding disorders
    • Blood disorders
    • Travelling with blood products
    • MyABDR app and the ABDR

Patient blood management

  • Home
  • Clinical guidance
  • Patient blood management

Overview of patient blood management

Patient blood management (PBM) improves patient outcomes by improving the patient's medical and surgical management in ways that boost and conserve the patient's own blood.

When a PBM approach is used, patients usually need fewer transfusions of donated blood components. This means patients avoid the risks associated with transfusion.

Reasons for PBM

PBM is based on evidence about blood transfusions and the appropriate use of donated blood. PBM encourages you to:

  • view a patient’s own blood as a valuable and unique natural resource that should be conserved and managed appropriately
  • acknowledge that altruistically donated blood is a valuable, unique and costly resource that is held in trust, and that it will only be used as therapy when there is evidence for potential benefit and potential harm will be minimised
  • consider transfusion alternatives
  • ensure quality products are available in a timely and safe manner
  • ensure potential hazards are considered and balanced against the benefits
  • explain the benefits and risks to the patient/relatives.

How PBM works

The patient's healthcare team works with the patient to determine their treatment management plan and how to use PBM. Under the Three Pillars of PBM model, the plan should make every effort to:

  1. optimise the patient’s own blood volume
  2. minimise blood loss
  3. optimise the patient’s physiological tolerance of anaemia.
     

The Three Pillars of PBM

The Three Pillars of PBM model shows how to use PBM practices to enhance and conserve a patient's own blood.

Pillar 1

Optimise red blood cell mass

Pillar 2

Minimise blood loss

Pillar 3

Manage anaemia

Perioperative

  • Detect/treat anaemia and iron deficiency.
  • Treat underlying causes.
  • Optimise haemoglobin.
  • Cease medications.

Intraoperative:

  • Time surgery with optimisation of erythropoiesis and red blood cell mass.

Postoperative:

  • Manage anaemia and iron deficiency.
  • Manage medications and potential interactions.

Perioperative:

  • Identify, manage and treat bleeding/bleeding risk.
  • Minimise phlebotomy.
  • Plan/rehearse procedure.

Intraoperative:

  • Use meticulous haemostasis / surgical / anaesthetic techniques.
  • Consider using cell salvage techniques.
  • Avoid coagulopathy.
  • Use appropriate patient positioning/warming.
  • Use appropriate pharmacological agents, where required.

Postoperative:

  • Monitor and manage post-operative bleeding.
  • Keep the patient warm.
  • Minimise phlebotomy.
  • Be aware of drug interactions and adverse events.
  • Treat infections promptly.

Perioperative:

  • Review and discuss with the patient their bleeding history and develop a management plan.
  • Estimate the patient's tolerance for blood loss.
  • Optimise cardiopulmonary function.

Intraoperative:

  • Optimise cardiopulmonary function.
  • Optimise ventilation and oxygenation.
  • Use restrictive transfusion strategies.

Postoperative:

  • Maximise oxygen delivery.
  • Minimise oxygen use.
  • Treat infections promptly.
  • Optimise tolerance of anaemia.
  • Use restrictive transfusion strategies.

 

Patient blood management video for patients

This video can help patients understand what PBM is.


Transcript is available here:

Patient blood management video for patients transcript (pdf)

 

PBM Guidelines

Available here.

Patient Blood Management Advisory Committee

The Patient Blood Management Advisory Committee gives us advice and guidance about implementing patient blood management in Australia. A key role is to support the development of the National Patient Blood Management Implementation Strategy.

Its members have expertise and knowledge in the health sector, blood management, education, quality and safety, and consumer issues.

Resources for implementing PBM

We developed the National Patient Blood Management Implementation Strategy 2017–2024 to increase awareness, improve understanding and support the implementation of PBM.

Since the PBM guidelines and strategy were launched, the use of red blood cells in Australia has reduced.

To implement PBM strategies, look at our tools and resources:

Patient Blood Management Implementation Resources (Opens in a new tab/window)

Blood and Inventory Management Resources (Opens in a new tab/window)

Other information

To promote safe transfusion practices, Lifeblood has developed a Transfusion Orientation Pack(Opens in a new tab/window).

The Australian & New Zealand Society of Blood Transfusion(Opens in a new tab/window) promotes improved knowledge and standards in the practice of blood transfusions.

Access courses on safe clinical transfusion practice and effective patient blood management through BloodSafe eLearning Australia(Opens in a new tab/window).

The Royal College of Pathologists of Australasia publishes frameworks and standards(Opens in a new tab/window) containing recommendations and guidelines for pathologists and pathology laboratories for the preparation of structured reports for iron studies.

Get in touch

For enquiries about the PBM Guidelines, contact:

Email: guidelines@blood.gov.au

Post:
Patient Blood Management Guidelines
National Blood Authority
Locked Bag 8430
Canberra ACT 2601

For general enquiries about PBM, please contact us.

Last updated: 27 Mar 2024

Back to top

The National Blood Authority acknowledges the Traditional Owners and Custodians of Country throughout Australia, and their continuing connection to land, water and community. We pay our respects to the people, the cultures and the elders past, present and emerging.

National Blood Authority

  • About the NBA
  • Work with us
  • Contact Us
  • Data and reporting
  • Freedom of information
  • Public interest disclosure
  • Resources
  • Accessibility
  • Privacy
  • Copyright
  • Disclaimer
  • BloodPortal Terms and Conditions of Use

Information

  • Blood Products
  • Managing blood supply
  • Supply systems
  • Clinical guidance
  • Patient information
  • Data and research
  • Website feedback